ASHM Report Back

Clinical posts from members and guests of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) from various international medical and scientific conferences on HIV, AIDS, viral hepatitis, and sexual health.

GS-7340 - cousin of tenofovir

Posted by on in New ARV Treatment, clinical trials emerging therapy
  • Font size: Larger Smaller
  • Hits: 3950
  • Print

The renal effects of tenofovir were associated with blood levels (abstract 603) at the conference. Another presentation (abstract 103) examined a prodrug of tenofovir, GS-7340, in a 10 day monotherapy study. This produg was associated with 88% lower plasma levels of tenofovir than when the currently prescribed prodrug TDF (tenofovir disproxil fumarate) was administered. It was highly potent and is likely to be studied further as an alternative to TDF.

Tagged in: CROI2012 GS-7340
  • No comments made yet. Be the first to submit a comment

Leave your comment

Guest
Guest Wednesday, 05 August 2020

Scholarships are now open for the Nurses & Pharmacists HIV Clinical Forum 2020, London, 13 November. You can apply… https://t.co/XF8dX43BWj

ASHM ASHM

ASHM invite you to register for an AIDS 2020 – 23rd International AIDS Conference Report Back, taking place from 5p… https://t.co/148X11GZx5

ASHM ASHM